AEON Biopharma GAAP EPS of $0.01 beats by $0.09
- AEON Biopharma press release (AEON): Q3 GAAP EPS of $0.01 beats by $0.09.
- The Company reported cash and cash equivalents of $11.4 million as of September 30, 2026, which does not include approximately $6.2 million of proceeds from the exercise of milestone warrants received
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.